Skip to content

Clinical trials

Cardiovascular Diseases trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Country / region: South Korea Clear all

109 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20052
20062
20071
20083
20095
20101
20113
20126
20134
20144
20156
20167
20174
20187
20197
20207
20217
20225
20236
20246
20257
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44
Unknown status23
Recruiting20
Terminated11
Active, not recruiting7
Not yet recruiting3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yonsei University10
Chong Kun Dang Pharmaceutical9
Seoul National University Bundang Hospital7
Seoul National University Hospital7
AstraZeneca4
GlaxoSmithKline4
Novartis Pharmaceuticals4
Samsung Medical Center4
Asan Medical Center3
Eli Lilly and Company3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases109
Coronary Artery Disease18
Atherosclerosis15
Heart Diseases12
Myocardial Infarction11
Acute Coronary Syndrome9
Coronary Disease9
Diabetes Mellitus, Type 29
Hypertension8
Stroke8

Trials

Showing 1 to 25 of 109. Each trial links to its page on Pharma Observatory.

9 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.